The Regional MSME Investment Fund for Sub-Saharan Africa S.A., SICAV-SIF, a société anonyme, qualifying as a société d’investissement à capital variable-fonds d’investissement specialisé (SICAV-SIF) under the Luxembourg Law of 13 February 2007, has its registered office at 31, Z.A. Bourmicht, L-8070 Bertrange, Luxembourg and is registered with the Registre de Commerce et des Sociétés in Luxembourg under number B 150766.
Subscribers
The content of the website is managed by Symbiotics Asset Management SA as investment manager regulated by the Swiss Financial Market Supervisory Authority (FINMA) on behalf of Regional MSME Investment Fund for Sub-Saharan Africa S.A. (“REGMIFA” or “the Fund”), an internally-managed AIF within the meaning of the Directive 2011/61/EU of 8 June 2011 on alternative investment fund managers (the “AIFM Directive”).
Country or regulatory requirements may prevent certain users from being offered certain services or financial products and engaging in business with REGMIFA. Access to this website is only intended for those subscribers in jurisdictions where the use of this website is permitted by law or regulation.
This website is neither directed at nor is the Fund intended for distribution or use by any person or entity who is a citizen or resident of or located in any locality, state, country, or jurisdiction where such distribution, publication, availability, or use would be contrary to law or regulation.
Persons who wish to access this website are required by Symbiotics Asset Management SA and REGMIFA to observe any legal or regulatory restrictions which may affect their eligibility to access the website or to subscribe to the investment products. Professional advice should be sought in case of doubt.
By continuing onto the website, I am affirming that I am eligible by applicable law to engage in business with REGMIFA.
EU Subscribers
The AIFM Directive shall not apply to the Fund in accordance with article 2(2) thereof. As a consequence, the Fund cannot benefit from the marketing passport provided under the AIMF Directive and as such the placement of the Fund’s Shares and Notes will not be carried out within the European Union under the passporting regime set out in the AIFM Law.
Swiss Subscribers
The investment products referred to on this website have not been approved for distribution to non-super-qualified investors in or from Switzerland by the Swiss Financial Market Supervisory Authority (FINMA). Accordingly, shares and notes of the Fund and information, documents or material pertaining to the Fund on the following pages may only be distributed in or from Switzerland to super-qualified investors. Agreement to this legal disclaimer doesn’t constitute an evidence according to art. 6 para.1, 5 CISO, or a written declaration according to art. 6a CISO.
General Information
To the best of my knowledge, after due enquiry, I am permitted by the laws of my jurisdiction of residence to access this website and the information contained herein.
The content of this website is for information purposes only and does not constitute an offer, solicitation, advice or recommendation to buy any investment, to engage in any other transaction or to provide any investment advice or service.
The information, opinions, and estimates expressed by analysts herein reflect judgments as of the publication date and are subject to change at any time. The information and opinions presented by these analysts have been obtained from sources believed to be reliable. Although all reasonable care was taken in gathering the information and formulating the opinions, Symbiotics and REGMIFA do not make any representation or warranty (including liability towards third parties) as to its accuracy or completeness. Accordingly, Symbiotics and REGMIFA accept no liability for any loss arising from the use of this website, which has been made available for information purposes only.
Investment decisions are made at my own risk. The information included on this website does not take into consideration the specific investment objectives, financial situation, or particular needs of anyone who may read it and invest in any investment product. Any reports are not to be relied upon in substitution for the exercise of independent judgment. The value and income of any investment products mentioned can vary upward or downward, affected by many factors including, but not limited to, changes in economic, financial, or political factors, time to maturity, market conditions, volatility, the credit quality of any issuer or reference issuer, and foreign currency rates. Accordingly, investors assume all risks and may receive back less than they had originally invested. Past performance should not be taken as an indication or guarantee of future performance, and Symbiotics and REGMIFA make no representation or warranty, expressed or implied, regarding future performance.
The Fund is only sold in accordance with the related legal offering documents.
